Springer Nature stock
Price history
+8.89% over the period1 year: from €20.80 (November 17, 2025) to €22.65 (November 17, 2026), +8.89%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | €22.65 |
| October 30, 2026 | €20.60 |
| September 30, 2026 | €20.25 |
| August 31, 2026 | €19.68 |
| July 31, 2026 | €18.50 |
| June 30, 2026 | €19.36 |
| May 29, 2026 | €19.26 |
| April 30, 2026 | €19.72 |
| March 31, 2026 | €18.04 |
| February 27, 2026 | €15.86 |
| January 30, 2026 | €17.60 |
| December 30, 2025 | €19.12 |
| November 28, 2025 | €21.35 |
| November 17, 2025 | €20.80 |
At a glance
The company
Publishes academic journals, scientific books, and educational content, and provides AI-powered research tools and healthcare information services
Latest results
Quarter to June 30, 2026 · EPS €0.41 (estimate €0.37)
TickerLandia's take on Springer Nature
- Cheaper than similar companies: trailing 12-month P/E 14 vs 17 (−21%) in a group of 7.
- Strong point: Market momentum (72/100 in its group). Weak point: Dividend (21/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−3.70% from the 52-week high
Analysts · 9 analysts
Average target€26.44+19.36% vs. price
Buy 8 · Hold 1 · Sell 0
TickerLandia Fingerprint: Springer Nature
Compared with similar companies: low dividend, strong momentum, and high profitability.
Financials and price compared with 8 companies in the publishing industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricelow34
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 13.7 36 Forward P/E 12.5 19 EV/EBITDA 7.99 21 Price/book 2.27 50 Price/sales 2.32 44 Profitabilityhigh70
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 24.1% 81 Gross margin 87.0% 94 Net margin 16.8% 69 ROE 17.1% 50 ROA 5.8% 56 Earnings stabilityaverage44
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.1% 69 Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 19 Growthlow32
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +3.00% 31 Earnings growth (year over year) −21.60% 21 Average revenue growth (3 years) +1.88% 44 Financial strengthaverage40
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 0.92 44 Interest coverage 4.43 31 Debt/equitycounts in reverse: lower means more financial strength 0.72 21 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.75 64 Dividendlow21
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 50.0% 36 Consecutive dividend years at least 2 years 19 Dividend yield 0.6% 7 Market momentumstrong72
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +14.40% 87 Relative strength (6 months) +6.53% 71 1-year return +6.49% 43 Distance from 200-day average +16.64% 87 Risklow39
How much the price swings.
Metric Value Position in group Volatility (60 days) 21.4% 25 Beta (1 year) 0.42 22 Maximum drawdown (12 months) 30.1% 69
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Springer Nature is cheaper than similar companies
Springer Nature's P/E (trailing 12 months): 13.7, −21% against the median of a group of 7 similar companies (17.5).
Compared with 7 similar companies
| Metric | Springer Nature | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 13.7 | Middle | |
| Forward P/E | 12.5 | Low | |
| Operating margin | 24.1% | High | |
| ROE | 17.1% | Middle | |
| Debt/equity | 0.72 | High |
Grey band: the middle half of the group; tick: the median; dot: Springer Nature. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€998.9M
Latest quarter · Q2 2026
Net income
€101.3M
Latest quarter · Q2 2026
Quarterly net margin
10.1%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- €4.53B
- P/E
- 13.7
- EPS
- €1.66
- Volume
- 63.91K
- Daily trading
- €1.04M
How Springer Nature is changing
All resultsRevenue grew 3.4% a year on average over the last 5 years
Operating margin rose from 18.5% to 24.0%
Shares outstanding up 4.7% in 5 years
Returns
Springer Nature returns with dividends
€1,000 invested in Springer Nature 1 year ago, on November 17, 2025, would be worth €1,136 today with dividends reinvested: +13.59% in total, +13.59% per year. On price alone it would be €1,089 (+8.89%).
| Period | Springer Nature | DAX | €1,000 becomes |
|---|---|---|---|
| 1 month | +8.89% | +2.87% | €1,089 |
| 6 months | +15.85% | +8.75% | €1,158 |
| Year to date | +18.46% | +6.35% | €1,185 |
| 1 year | +13.59% | +10.41% | €1,136 |
Over the last 6 months it has done better than 77% of the stocks in the Communications sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. DAX: with dividends. Calculate your investment
The chart in detail
Springer Nature: technical analysis
Springer Nature is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 19.1% below its all-time closing high (€27.38, December 27, 2024).
- Trend
- Upward
- RSI (14 sessions)
- 61
- Between 30 and 70
- vs 200-session average
- +16.64%
Active signals
New 52-week high.
since November 11, 2026
Trading on November 17, 2026 was 3.6 times the 20-session average.
Support and resistance
Price areas where Springer Nature has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price€22.15
- Support€21.40−3.39%4 touches, last on October 26, 2026
- Support€20.85−5.87%4 touches, last on September 28, 2026
- Support€20.04−9.52%7 touches, last on October 28, 2026
Volatility and risk
Over the last year it has moved less than the DAX.
- Beta (1 year) vs DAX
- 0.42
- Volatility (60 sessions, annualised)
- 21.4%
- Largest fall in the last year
- −30.12%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
The company
Springer Nature and its competitors
Founded in 1842, Springer Nature AG & Co. KGaA is based in Berlin, Germany, and operates as a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH. The company engages in publishing in Germany, the United Kingdom, the United States and other markets internationally.
- Headquarters
- Berlin, Germany
- Employees
- 9,400
- Founded
- 1842
- Chief executive
- Franciscus Peeters
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Springer NatureSPG | $4.98B | 24.1% | 13.7 | +15.85% |
| PearsonPSON | $10.47B | 14.1% | 26.4 | +18.10% |
| InformaINF | $15.91B | 18.6% | 52.2 | +8.78% |
| Alma MediaALMA | $1.24B | 26.4% | 17.5 | +7.81% |
| Sonaecom, SGPSSNC | $987.87M | -99.9% | 10.5 | 0.00% |
| Arnoldo Mondadori EditoreMN | $576.17M | 8.4% | 10.6 | −5.52% |
Same industry or related industries, similar size. Compare Springer Nature with its competitors · Full profile